Company profile
Herborium Group, Inc.
OTC: HBRM · Healthcare · Drug Manufacturers - Specialty & Generic
#892 of 1,418 Healthcare companies by revenue26th-percentile growth
EA Score
36DFH 32DQ —GM 45SS 41
v0.1 · 45/100 weight · provisional
↑ listing tenure, growth stability · ↓ workforce scale, balance-sheet leverage
Methodology →Revenue TTM
$787.0k
Rev growth YoY (TTM)
-3.4%
Net income (FY)
-$154.8k
Employees
2
as of 2026-08-26
Market cap
$1.1M
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$788.3k$788.3k2025
Net income-$154.8k-$154.8k2025
Operating income-$238.0k-$238.0k2025
Total assets$142.8k$142.8k2025
Liabilities$4.1M$4.1M2025
Equity-$4.3M-$4.3M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Herborium Group, Inc.’s revenue?
Herborium Group, Inc. booked $788.3k in FY2025 revenue, contracting 25% year over year — slower than 74% of Healthcare companies we track, at a -19.6% net margin.
Peers · Healthcare
ImageneBio Inc48DBioCorRx Inc.44DSeres Therapeutics, Inc.52DRising Biosciences, Inc.——Tivic Health Systems, Inc.34DParadigm Medical Industries, Inc.——Neighbors
Bergen →Key facts
CEOAgnes Olszewski
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersFort Lee, NJ
ExchangeOTC: HBRM
Employees2
IPO date1998-07-13
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.